人工涙液の世界市場

◆英語タイトル:Artificial Tears : Global Strategic Business Report
◆商品コード:GIA60141
◆発行会社(調査会社):Global Industry Analysts
◆発行日:2016年1月
◆ページ数:221
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(DRM付き)USD4,800 ⇒換算¥542,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Industry Analysts社の日本における正規販売代理店です。Global Industry Analysts社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、人工涙液の世界市場について調査・分析し、人工涙液の世界市場規模、市場動向、市場予測、関連企業情報などをお届けいたします。
【レポートの概要】

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 68 companies including many key and niche players such as –
Abbott Medical Optics Inc.
Allergan, Inc.
Akorn, Inc.
Bausch & Lomb Incorporated
Johnson & Johnson

【レポートの目次】

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
Dry Eyes – An Emerging Lucrative Segment of Ophthalmology Market
Table 1: Global Ophthalmology Market (2015): Percentage Share Breakdown by Product Segment (includes corresponding Graph/Chart)
Artificial Tears: The First Line of Treatment for Dry Eyes
Current & Future Analysis
Developing Countries Display Untapped Potential
Under-reporting of DES Condition Stifles Market Opportunities
Prevalence and Incidence of Dry Eye Syndrome
Table 2: Prevalence of Dry Eye Syndrome Across Select Countries (in %) (includes corresponding Graph/Chart)
Select Stats on Prevalence Rates
Concentrated Prescription Dry Eye Products Market Benefits OTC Market
Aging Population – A Major Growth Driver
Table 3: Global Population Demographics (2014 & 2020P): Percentage Breakdown of Population by Age Group – Below 40 Years and 40 Years & Above (includes corresponding Graph/Chart)
Table 4: Global Population Statistics for 65+ Age Group (2014) (includes corresponding Graph/Chart)
Market Challenges
Lack of Clear Product Differentiation Leads to Confusion
Drug Formulation Fraught with Difficulties
Low Patient Compliance Limits Market Opportunities
2. NOTEWORTHY MARKET TRENDS
Preference for Preservative-Free Artificial Tears on Rise
Ongoing Technology Evolution Boosts Growth
Artificial Tears for Dry Eye Syndrome-Single-use (Unit dose)
Artificial Tears for Dry Eye Syndrome -Multi dose
Management of Dry Eyes Post Eye Surgery Drives Demand
Growth in Mobile Workforce and Number of Smartphone Addicts Augurs Well for Market Growth
Rise in Contact Lens Wearers – Another Opportunity Market
Table 5: Penetration of Contact Lenses in Select Countries/Regions (2013) (includes corresponding Graph/Chart)
Focus Grows on Formulating the Right Artificial Tears for Contact Lens Wearers
Environmental Factors – Playing an Important Role
Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
Direct-to-Customer Promotions: A Primary Marketing Strategy
3. DRY EYE SYNDROME – INDUSTRY DYNAMICS
Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
Bridging Chasm between Diagnosis and Treatment of Dry Eye Syndrome
Competition
Leading Drugs in the Pipeline
Shire Plc Eyes FDA Re-submission after Positive Phase III Results of Lifitegrast
First Patients Enrolled in Phase2b/3 of RegeneRx’s
Mimetogen’s MIM-D3 Promises Huge Potential
Clouds of Uncertainty Looms over Santen’s Ikervis
Herantis Pharma Kick Starts Phase 2 Study of Cis-UCA Eye Drops
Mitotech’s SkQ1 Displays Positive Results
Novaliq’s CyclASol Enters Phase II Development Stage
Drugs in the Late-Stage Pipeline for Dry Eye Treatment (2015)
Other Promising Solutions in the Artificial Tear Market
Retaine MGD
Rebagen
Tofacitinib
Positive Effects of Autologous Serum Eyedrops
Resolvins – Capturing Fancy
Oculeve to Continue Testing
Gains Prominence
Role of Steroids in DES Treatment
Carbomer-Based Artificial Tear Formulations
Androgen and Estrogen Receptor Inhibitors
4. PRODUCT OVERVIEW
Dry Eye – A Common Ophthalmic Condition
Causes of Dry Eyes
Diagnosis of Dry Eye Syndrome
Treatment Strategies
Artificial Tears – A Brief Overview
Product Options for Dry Eye Syndrome: Breakdown by Palliative Therapies and Targeted Therapies
KCS Inflammation Cycle
Common Symptoms of KCS
Risk Factors for Dry Eye Disease
Impact of Dry Eye Syndrome on Routine Daily Life Activities: Ranking based on Intensity of Impact Felt by Patients
Types of Artificial Tears
Artificial Tears Usage and Dosage
Drug Contraindications or Interactions
Osmolarity
Table 6: Osmolarity of Select Ocular Brands (includes corresponding Graph/Chart)
Alternate Treatment Methods
Evolution of Artificial Tears
First-Generation
Second-Generation
Third-Generation
Fourth-Generation
Novel Approaches to Revolutionize Dry Eye Therapy
Anti-Inflammatory Drugs
Mucin Secretagogues
Hormonal Therapies
Drugs
Muco-Mimetics
Barrier-function Drugs
5. PRODUCT LAUNCHES/APPROVALS/ INTRODUCTIONS
Allergan Submits PAS for RESTASIS MDPF
NICE Issues FAD Recommending Santen’s IKERVIS for Severe Keratitis
Allergan plc Launches REFRESH OPTIVE Gel Drops
URSAPHARM Collaborates with Novaliq and Launches EvoTears
Shire plc Announces FDA’s Priority Review Designation for Lifitegrast
Avizorex Pharma Receives Patent for
SilkTears Develops
Protein for Tear Formulations
Bausch & Lomb Launches Soothe® Xtra Protection (XP) Eye Drops
Santen Europe Launches Ocutears® in Bulgaria
Similasan Introduces Similasan Complete Eye Relief
Nicox S.A. Announces European Launch of Xailin™
DiagnosTear Receives Approvals to Start Clinical Study with TeaRx
Neuroptis Bitoech Announces Positive Preclinical Trial Results of ML7 Eye Drops
Santen Pharmaceuticals Launches OTC Eye Drops Soft Santear
Bausch & Lomb Acquires License for Mimetogen’s MIM-D3
Candorvision Launches Hylo™ for Dry Eye Disease
6. RECENT INDUSTRY ACTIVITY
Allergan and Pfizer Enter Into Merger Agreement
Allergan Enters into Licensing Agreement with Mimetogen for Tavilermide
Shire Acquires Foresight Biotherapeutics
BioLight Life Sciences Enters Into Collaboration Agreement with Ora, Inc.
Collaboration between Valeant and Croma to Expand Bausch + Lomb’s Portfolio
NovaMedica and SIFI Enter Into Marketing Agreement
NicOx S.A. Acquires Eupharmed Srl
7. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Medical Optics Inc. (US)
Allergan, Inc. (US)
Akorn, Inc. (US)
Bausch & Lomb Incorporated. (US)
Johnson & Johnson (US)
Novartis International AG (Switzerland)
Alcon, Inc. (Switzerland)
Santen Pharmaceuticals Co, Ltd. (Japan)
Novagali Pharma S.A. (France)

8. GLOBAL MARKET PERSPECTIVE
Table 7: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 8: World Historic Review for Artificial Tears by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
Table 9: World 14-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
A. Market Analysis
Current and Future Analysis
Table 10: Prevalence of Dry Eye in the United States for the Years 2006, 2009, 2012, & 2015 (In Millions of Individuals) (includes corresponding Graph/Chart)
Table 11: Number of Individuals Treated for Dry Eye in the United States (In 000s) for the Years 2006, 2009 & 2012 (includes corresponding Graph/Chart)
Demographics Remain an Important Growth Driver
Table 12: US Population Demographics (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
Table 13: Prevalence of Dry Eye Condition in the US (2014) (includes corresponding Graph/Chart)
Table 14: US Women Population (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
Eye Care Market Thrives Due to Lifestyle and Environmental Factors
Air Pollution Bears Close Association with DES Risk
Thriving OTC Market Offers Good Potential for Artificial Tears
Restasis- The Leading Drug for Dry Eyes
Product Launches
Strategic Corporate Developments
Select Players
B. Market Analytics
Table 15: US Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 16: US Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
2. CANADA
A. Market Analysis
Current and Future Analysis
Product Launch
B. Market Analytics
Table 17: Canadian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 18: Canadian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
3. JAPAN
A. Market Analysis
Current and Future Analysis
Eye Care Products Targeting Specific Consumer Segments Drive the Market
Table 19: Japanese Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Rohto Pharmaceutical, and Others (includes corresponding Graph/Chart)
Product Launch
Select Players
B. Market Analytics
Table 20: Japanese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 21: Japanese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
4. EUROPE
A. Market Analysis
Current and Future Analysis
Ophthalmic Pharmaceutical Drugs Market in Europe
Artificial Tears Reimbursement Overview
B. Market Analytics
Table 22: European Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 23: European Historic Review for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
Table 24: European 14-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A. Market Analysis
Current and Future Analysis
High Pollen Count Boosts Eye Care Market
Table 25: French Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Johnson & Johnson Santé Beauté, Laboratoires Pierre Fabre, and Others (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Development
B. Market Analytics
Table 26: French Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 27: French Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
4b. GERMANY
A. Market Analysis
Current and Future Analysis
Digitalised Lifestyle Promotes Eye Care Market
Table 28: German Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Gerhard Mann Chem-Pharm Fabrik, and Others (includes corresponding Graph/Chart)
Product Launch
B. Market Analytics
Table 29: German Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 30: German Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
4c. ITALY
A. Market Analysis
Current and Future Analysis
Dry Eye Syndrome Drives Eye Care Product Market
B. Market Analytics
Table 31: Italian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 32: Italian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A. Market Analysis
Current and Future Analysis
High Smartphones’ and Tablets’ Usage Drive Eye Care Product Market
Product Launch
Strategic Corporate Development
Spectrum Thea Pharmaceuticals Limited – A UK Key Player
B. Market Analytics
Table 33: UK Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 34: UK Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
4e. SPAIN
A. Market Analysis
Current and Future Analysis
Product Launch
B. Market Analytics
Table 35: Spanish Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 36: Spanish Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
4f. RUSSIA
A. Market Analysis
Current and Future Analysis
Cost-Minded Consumers Restrain the Market
Strategic Corporate Development
B. Market Analytics
Table 37: Russian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 38: Russian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)

4g. REST OF EUROPE
A. Market Analysis
Current and Future Analysis
Product Launches
Strategic Corporate Development
Key Players
B. Market Analytics
Table 39: Rest of Europe Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 40: Rest of Europe Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
A. Market Analysis
Current and Future Analysis
Opportunities Abound for Indian OTC Market
B. Market Analytics
Table 41: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - China, India, and Rest of Asia Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 42: Asia-Pacific Historic Review for Artificial Tears by Geographic Region - China, India, and Rest of Asia Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
Table 43: Asia-Pacific 14-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A. Market Analysis
Current and Future Analysis
Modern Lifestyle Trends Boost Eye Care Product Market
Table 44: Chinese Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Mentholatum (Zhongshan) Pharmaceuticals Co. Ltd., and Others (includes corresponding Graph/Chart)
B. Market Analytics
Table 45: Chinese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 46: Chinese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
5b. INDIA
A. Market Analysis
Current and Future Analysis
Prescription-Based Products Dominate the Market
Table 47: Indian Eye Care Market by leading Player (2015): Percentage Share Breakdown of Revenues for Allergan India, and Others (includes corresponding Graph/Chart)
B. Market Analytics
Table 48: Indian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 49: Indian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A. Market Analysis
Current and Future Analysis
B. Market Analytics
Table 50: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 51: Rest of Asia-Pacific Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
6. LATIN AMERICA
A. Market Analysis
Current and Future Analysis
Alcon: The Clear Market Leader in Brazilian Eye Care Market
Table 52: Brazilian Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Alcon Laboratórios do Brasil, and Others (includes corresponding Graph/Chart)
Mexico - Restrained by Inadequate Diagnosis
Table 53: Mexican Eye Care Market by Leading Player (2015): Percentage Share Breakdown of Revenues for Alcon Laboratorios, Laboratorios Sophia, and Others (includes corresponding Graph/Chart)
B. Market Analytics
Table 54: Latin American Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 55: Latin American Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
7. REST OF WORLD
A. Market Analysis
Current and Future Analysis
Product Launch
Strategic Corporate Development
B. Market Analytics
Table 56: Rest of World Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 Through 2020 (includes corresponding Graph/Chart)
Table 57: Rest of World Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 Through 2013 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 68 (including Divisions/Subsidiaries - 74)
The United States (25)
Canada (3)
Japan (4)
Europe (22)
- France (3)
- Germany (3)
- The United Kingdom (5)
- Italy (1)
- Spain (1)
- Rest of Europe (9)
Asia-Pacific (Excluding Japan) (17)
Africa (2)
Middle-East (1)

★調査レポート[人工涙液の世界市場] (コード:GIA60141)販売に関する免責事項を必ずご確認ください。
★調査レポート[人工涙液の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆